001     151070
005     20240423115942.0
024 7 _ |a pmc:PMC7072321
|2 pmc
024 7 _ |a 10.3390/biom10020290
|2 doi
024 7 _ |a altmetric:76195372
|2 altmetric
024 7 _ |a pmid:32059611
|2 pmid
037 _ _ |a DZNE-2020-01055
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Llorens, Franc
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease
260 _ _ |a Basel
|c 2020
|b MDPI
264 _ 1 |3 online
|2 Crossref
|b MDPI AG
|c 2020-02-12
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713783834_6655
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a https://www.mdpi.com/2218-273X/10/2/290
520 _ _ |a Human prion diseases are classified into sporadic, genetic, and acquired forms. Within this last group, iatrogenic Creutzfeldt–Jakob disease (iCJD) is caused by human-to-human transmission through surgical and medical procedures. After reaching an incidence peak in the 1990s, it is believed that the iCJD historical period is probably coming to an end, thanks to lessons learnt from past infection sources that promoted new prion prevention and decontamination protocols. At this point, we sought to characterise the biomarker profile of iCJD and compare it to that of sporadic CJD (sCJD) for determining the value of available diagnostic tools in promptly recognising iCJD cases. To that end, we collected 23 iCJD samples from seven national CJD surveillance centres and analysed the electroencephalogram and neuroimaging data together with a panel of seven CSF biomarkers: 14-3-3, total tau, phosphorylated/total tau ratio, alpha-synuclein, neurofilament light, YKL-40, and real-time quaking induced conversion of prion protein. Using the cut-off values established for sCJD, we found the sensitivities of these biomarkers for iCJD to be similar to those described for sCJD. Given the limited relevant information on this issue to date, the present study validates the use of current sCJD biomarkers for the diagnosis of future iCJD cases.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2020-02-12
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0/
588 _ _ |a Dataset connected to CrossRef
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Biomarkers: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Corneal Transplantation: adverse effects
|2 MeSH
650 _ 2 |a Creutzfeldt-Jakob Syndrome: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Creutzfeldt-Jakob Syndrome: diagnostic imaging
|2 MeSH
650 _ 2 |a Creutzfeldt-Jakob Syndrome: epidemiology
|2 MeSH
650 _ 2 |a Dura Mater: transplantation
|2 MeSH
650 _ 2 |a Electroencephalography
|2 MeSH
650 _ 2 |a Encephalopathy, Bovine Spongiform: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Encephalopathy, Bovine Spongiform: diagnostic imaging
|2 MeSH
650 _ 2 |a Encephalopathy, Bovine Spongiform: epidemiology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Homozygote
|2 MeSH
650 _ 2 |a Human Growth Hormone: adverse effects
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Iatrogenic Disease
|2 MeSH
650 _ 2 |a Kaplan-Meier Estimate
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Methionine: genetics
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Neuroimaging
|2 MeSH
650 _ 2 |a Phenotype
|2 MeSH
650 _ 2 |a Polymorphism, Genetic
|2 MeSH
650 _ 2 |a Prion Diseases: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Prion Diseases: diagnostic imaging
|2 MeSH
650 _ 2 |a Prion Proteins: metabolism
|2 MeSH
650 _ 2 |a Registries
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Sex Factors
|2 MeSH
650 _ 2 |a Time Factors
|2 MeSH
700 1 _ |a Villar-Piqué, Anna
|0 P:(DE-HGF)0
|b 1
|e Corresponding author
700 1 _ |a Hermann, Peter
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Schmitz, Matthias
|0 P:(DE-2719)9000287
|b 3
700 1 _ |a Calero, Olga
|b 4
700 1 _ |a Stehmann, Christiane
|0 0000-0001-8282-9151
|b 5
700 1 _ |a Sarros, Shannon
|b 6
700 1 _ |a Moda, Fabio
|0 0000-0002-2820-9880
|b 7
700 1 _ |a Ferrer, Isidre
|0 0000-0001-9888-8754
|b 8
700 1 _ |a Poleggi, Anna
|0 0000-0001-7094-7767
|b 9
700 1 _ |a Pocchiari, Maurizio
|0 0000-0002-7269-2486
|b 10
700 1 _ |a Catania, Marcella
|b 11
700 1 _ |a Klotz, Sigrid
|b 12
700 1 _ |a O’Regan, Carl
|b 13
700 1 _ |a Brett, Francesca
|b 14
700 1 _ |a Heffernan, Josephine
|b 15
700 1 _ |a Ladogana, Anna
|b 16
700 1 _ |a Collins, Steven J.
|b 17
700 1 _ |a Calero, Miguel
|0 0000-0001-5366-3324
|b 18
700 1 _ |a Kovacs, Gabor G.
|b 19
700 1 _ |a Zerr, Inga
|0 P:(DE-2719)2000058
|b 20
|e Last author
770 _ _ |a Prion Disease Biomarkers: Recent Advances
773 1 8 |a 10.3390/biom10020290
|b : MDPI AG, 2020-02-12
|n 2
|p 290
|3 journal-article
|2 Crossref
|t Biomolecules
|v 10
|y 2020
|x 2218-273X
773 _ _ |a 10.3390/biom10020290
|g Vol. 10, no. 2, p. 290 -
|0 PERI:(DE-600)2701262-1
|n 2
|p 290
|t Biomolecules
|v 10
|y 2020
|x 2218-273X
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/151070/files/DZNE-2020-01055.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/151070/files/DZNE-2020-01055.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:151070
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000287
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)2000058
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BIOMOLECULES : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-01-07T14:30:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-01-07T14:30:28Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-22
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|f 2020-01-16
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b BIOMOLECULES : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-01-16
920 1 _ |0 I:(DE-2719)1440011-1
|k AG Zerr
|l Translational Studies and Biomarker
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1440011-1
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bmb/66.1.121
|2 Crossref
|o 10.1093/bmb/66.1.121
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bmb/66.1.241
|2 Crossref
|o 10.1093/bmb/66.1.241
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bmb/66.1.213
|2 Crossref
|o 10.1093/bmb/66.1.213
999 C 5 |9 -- missing cx lookup --
|a 10.1093/bmb/66.1.255
|2 Crossref
|o 10.1093/bmb/66.1.255
999 C 5 |9 -- missing cx lookup --
|a 10.1016/B978-0-444-63945-5.00012-X
|2 Crossref
|o 10.1016/B978-0-444-63945-5.00012-X
999 C 5 |9 -- missing cx lookup --
|a 10.3201/eid1806.120116
|2 Crossref
|o 10.3201/eid1806.120116
999 C 5 |9 -- missing cx lookup --
|a 10.3171/2016.5.FOCUS15126
|2 Crossref
|o 10.3171/2016.5.FOCUS15126
999 C 5 |9 -- missing cx lookup --
|a 10.1111/bpa.12696
|2 Crossref
|o 10.1111/bpa.12696
999 C 5 |9 -- missing cx lookup --
|a 10.14252/foodsafetyfscj.2016021
|2 Crossref
|o 10.14252/foodsafetyfscj.2016021
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000231528.65069.3f
|2 Crossref
|o 10.1212/01.wnl.0000231528.65069.3f
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.55.8.1075
|2 Crossref
|o 10.1212/WNL.55.8.1075
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awv235
|2 Crossref
|o 10.1093/brain/awv235
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000230159.67128.00
|2 Crossref
|o 10.1212/01.wnl.0000230159.67128.00
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.clinph.2004.05.032
|2 Crossref
|o 10.1016/j.clinph.2004.05.032
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-009-0026-z
|2 Crossref
|o 10.1007/s00415-009-0026-z
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000266624.63387.4a
|2 Crossref
|o 10.1212/01.wnl.0000266624.63387.4a
999 C 5 |y 2003
|2 Crossref
|o 2003
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.410430109
|2 Crossref
|o 10.1002/ana.410430109
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.dadm.2018.06.005
|2 Crossref
|o 10.1016/j.dadm.2018.06.005
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nprot.2016.120
|2 Crossref
|o 10.1038/nprot.2016.120
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e3181a96e5d
|2 Crossref
|o 10.1212/WNL.0b013e3181a96e5d
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.55.6.811
|2 Crossref
|o 10.1212/WNL.55.6.811
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s004399900124
|2 Crossref
|o 10.1007/s004399900124
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12035-015-9167-5
|2 Crossref
|o 10.1007/s12035-015-9167-5
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000454802
|2 Crossref
|o 10.1159/000454802
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12035-018-1313-4
|2 Crossref
|o 10.1007/s12035-018-1313-4
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2017.12.008
|2 Crossref
|o 10.1016/j.jalz.2017.12.008
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s13024-017-0226-4
|2 Crossref
|o 10.1186/s13024-017-0226-4
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2015.10.009
|2 Crossref
|o 10.1016/j.jalz.2015.10.009
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2016.09.013
|2 Crossref
|o 10.1016/j.jalz.2016.09.013
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12035-015-9133-2
|2 Crossref
|o 10.1007/s12035-015-9133-2
999 C 5 |9 -- missing cx lookup --
|a 10.1038/s41598-019-38520-y
|2 Crossref
|o 10.1038/s41598-019-38520-y
999 C 5 |9 -- missing cx lookup --
|a 10.1097/WAD.0b013e31824d578a
|2 Crossref
|o 10.1097/WAD.0b013e31824d578a
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awm063
|2 Crossref
|o 10.1093/brain/awm063
999 C 5 |9 -- missing cx lookup --
|a 10.2188/jea.JE20100085
|2 Crossref
|o 10.2188/jea.JE20100085
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awh249
|2 Crossref
|o 10.1093/brain/awh249
999 C 5 |9 -- missing cx lookup --
|a 10.1054/jocn.1999.0193
|2 Crossref
|o 10.1054/jocn.1999.0193
999 C 5 |9 -- missing cx lookup --
|a 10.1590/S0004-282X2002000300022
|2 Crossref
|o 10.1590/S0004-282X2002000300022
999 C 5 |9 -- missing cx lookup --
|a 10.3346/jkms.2011.26.11.1515
|2 Crossref
|o 10.3346/jkms.2011.26.11.1515
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1471-2377-11-120
|2 Crossref
|o 10.1186/1471-2377-11-120
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroscience.2016.02.057
|2 Crossref
|o 10.1016/j.neuroscience.2016.02.057
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-019-09537-0
|2 Crossref
|o 10.1007/s00415-019-09537-0
999 C 5 |9 -- missing cx lookup --
|a 10.1186/1471-2377-12-153
|2 Crossref
|o 10.1186/1471-2377-12-153
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s40478-015-0214-2
|2 Crossref
|o 10.1186/s40478-015-0214-2
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.63.2.288
|2 Crossref
|o 10.1001/archneur.63.2.288
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000005860
|2 Crossref
|o 10.1212/WNL.0000000000005860
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e31821a4439
|2 Crossref
|o 10.1212/WNL.0b013e31821a4439
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awp191
|2 Crossref
|o 10.1093/brain/awp191
999 C 5 |9 -- missing cx lookup --
|a 10.1001/jamaneurol.2019.1534
|2 Crossref
|o 10.1001/jamaneurol.2019.1534
999 C 5 |9 -- missing cx lookup --
|a 10.1038/srep38737
|2 Crossref
|o 10.1038/srep38737
999 C 5 |9 -- missing cx lookup --
|a 10.1111/ene.13389
|2 Crossref
|o 10.1111/ene.13389
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pone.0135458
|2 Crossref
|o 10.1371/journal.pone.0135458
999 C 5 |9 -- missing cx lookup --
|a 10.1002/acn3.266
|2 Crossref
|o 10.1002/acn3.266
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-017-1683-0
|2 Crossref
|o 10.1007/s00401-017-1683-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/B978-0-444-63945-5.00019-2
|2 Crossref
|o 10.1016/B978-0-444-63945-5.00019-2
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jocn.2018.09.031
|2 Crossref
|o 10.1016/j.jocn.2018.09.031
999 C 5 |9 -- missing cx lookup --
|a 10.1186/s13195-017-0331-1
|2 Crossref
|o 10.1186/s13195-017-0331-1
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-150897
|2 Crossref
|o 10.3233/JAD-150897


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21